World J Diabetes 15(5):818822 Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Nvoa F et al (2023) Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure
This is a well-executed upgrade
"You should feel informed and empowered before starting any new medication." That's the goal of this guide: to explain the most common GLP-1 drug side effects, when they tend to show up and what you can do to minimize or manage them no speed-reading voiceover required
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials
Khan SS, Grobman WA, Kazi DS
Neither is approved for anti-aging or general fat loss, and both are prohibited in sport by WADA